We’ve all seen the headlines. Whether it’s ‘Waiting lists for cancer treatment soar’ in the Express, the Mail talking about…
NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective
As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority
New reports highlight the impact of workforce issues on the ongoing patient backlog and patient outcomes across UK nations.
A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer
New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.
A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.